1. Home
  2. IDYA vs KARO Comparison

IDYA vs KARO Comparison

Compare IDYA & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • KARO
  • Stock Information
  • Founded
  • IDYA 2015
  • KARO 2001
  • Country
  • IDYA United States
  • KARO Singapore
  • Employees
  • IDYA N/A
  • KARO N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • KARO Computer Software: Prepackaged Software
  • Sector
  • IDYA Health Care
  • KARO Technology
  • Exchange
  • IDYA Nasdaq
  • KARO Nasdaq
  • Market Cap
  • IDYA 1.9B
  • KARO 1.9B
  • IPO Year
  • IDYA 2019
  • KARO 2021
  • Fundamental
  • Price
  • IDYA $20.79
  • KARO $48.56
  • Analyst Decision
  • IDYA Strong Buy
  • KARO Buy
  • Analyst Count
  • IDYA 13
  • KARO 2
  • Target Price
  • IDYA $53.42
  • KARO $55.50
  • AVG Volume (30 Days)
  • IDYA 1.1M
  • KARO 115.4K
  • Earning Date
  • IDYA 08-05-2025
  • KARO 07-17-2025
  • Dividend Yield
  • IDYA N/A
  • KARO 2.27%
  • EPS Growth
  • IDYA N/A
  • KARO 24.98
  • EPS
  • IDYA N/A
  • KARO 1.60
  • Revenue
  • IDYA $7,000,000.00
  • KARO $245,745,961.00
  • Revenue This Year
  • IDYA $101.20
  • KARO $18.73
  • Revenue Next Year
  • IDYA $286.70
  • KARO $14.86
  • P/E Ratio
  • IDYA N/A
  • KARO $30.47
  • Revenue Growth
  • IDYA N/A
  • KARO 8.61
  • 52 Week Low
  • IDYA $13.45
  • KARO $28.04
  • 52 Week High
  • IDYA $44.42
  • KARO $63.36
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 62.23
  • KARO 42.74
  • Support Level
  • IDYA $21.08
  • KARO $46.00
  • Resistance Level
  • IDYA $22.37
  • KARO $47.94
  • Average True Range (ATR)
  • IDYA 0.92
  • KARO 2.24
  • MACD
  • IDYA -0.09
  • KARO -1.06
  • Stochastic Oscillator
  • IDYA 61.72
  • KARO 13.33

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

Share on Social Networks: